ABOUT INNOVATE BIOPHARMACEUTICALS


Innovate, a privately held clinical stage biotechnology company, is focused on developing novel gastroenterology medicines. Our pipeline includes drug candidates for Celiac Disease and for mild to moderate ulcerative colitis, along with Secretin which improves pancreatic duct visualization in MRCP procedures. The Company is led by a strong management team with extensive business and regulatory experience. Innovate has all global rights to the products which are backed by more than 150 patents in the US, EU, and Japan.

Subscribe to Receive Innovate News and Updates By Email